OACC - NASDAQ
Oaktree Acquisition Corp. III Life Sciences
$10.63
-0.19%Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
At a Glance
Live Snapshotoacc
Common Stock
Last Annual Value
201.56M
3-Year CAGR
1%
5-Year CAGR
1%
10-Year CAGR
%
Oaktree Acquisition Corp. III Life Sciences Competitors Analysis of Common Stock
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC | 201.56M | N/A | N/A | N/A | |
 Rithm Acquisition Corp. NYSE:RAC | 235.99M | N/A | N/A | N/A | |
 FACT II Acquisition Corp NASDAQ:FACT | 183.79M | 2872.2% | -11.8% | N/A | |
 SilverBox Corp IV NYSE:SBXD | 213.35M | N/A | N/A | N/A | |
239.04M | N/A | N/A | N/A | ||
 Graf Global Corp. AMEX:GRAF | 245.61M | 7431.1% | N/A | N/A | |
 Legato Merger Corp. III AMEX:LEGT | 218.85M | 7432.8% | N/A | N/A | |
0.00 | N/A | N/A | N/A | ||
247.75M | N/A | N/A | N/A | ||
 Soulpower Acquisition Corp. NYSE:SOUL | 257.62M | N/A | N/A | N/A |
Oaktree Acquisition Corp. III Life Sciences Fair Value Envelope
Related Guides
Continue your OACC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.